Review The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.
Schott G, Pachl H, Limbach U, Gundert-Remy U, Lieb K, Ludwig WD. Dtsch Arztebl Int. 2010 Apr; 107(17):295-301. Epub 2010 Apr 30.